Gerresheimer AG (ETR:GXI – Get Free Report) traded up 0.9% during mid-day trading on Wednesday . The company traded as high as €25.26 and last traded at €24.56. 217,338 shares traded hands during mid-day trading, an increase of 54% from the average session volume of 140,925 shares. The stock had previously closed at €24.34.
Gerresheimer Price Performance
The company has a current ratio of 0.80, a quick ratio of 0.40 and a debt-to-equity ratio of 87.94. The stock has a market cap of $840.86 million, a PE ratio of 7.36, a P/E/G ratio of 0.82 and a beta of 0.94. The company has a fifty day moving average of €32.15 and a 200-day moving average of €43.46.
About Gerresheimer
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
Further Reading
- Five stocks we like better than Gerresheimer
- Ride Out The Recession With These Dividend Kings
- onsemi Places a $6 Billion Bet on Its Own Stock
- Why Invest in 5G? How to Invest in 5G Stocks
- HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
- Investing in Commodities: What Are They? How to Invest in Them
- End the Year Strong With These 3 Comeback Champions
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.
